Genomictree Market Cap

Genomictree has a market cap or net worth of 478.78 billion as of March 20, 2026. Its market cap has increased by 9.42% in one year.

Market Cap

478.78B

Enterprise Value

404.02B

Revenue

3.76B

Ranking

n/a

PE Ratio

n/a

Stock Price

19,730.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 478.78B, an increase of 711.51%. That is a compound annual growth rate of 26.32%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	478.78B	-27.39%
Dec 30, 2025	659.41B	34.41%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MEDIPOST	879.43B
Medy-Tox	755.32B
Green Cross Holdings	634.72B
SillaJen	495.89B
Anterogen.Co.,Ltd.	439.27B
BINEX	400.33B
GC Cell	379.44B
JETEMA,	315.74B

Market Cap Rankings